Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Bluebird Bio, Inc. (BLUE)  
$1.28 0.09 (6.23%) as of 4:30 Thu 3/28


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 139,126,000
Market Cap: 178.08(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.9052 - $5.03
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ss-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 31,007 35,533 57,514 116,582
Total Sell Value $40,857 $61,294 $139,194 $443,003
Total People Sold 4 5 5 9
Total Sell Transactions 8 9 12 23
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 939
  Page 1 of 38  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Klima Thomas J See Remarks   •       –      –    2024-03-04 4 S $1.53 $6,986 D/D (4,573) 124,840 11%     
   Obenshain Andrew President and CEO   •       •      –    2024-03-04 4 S $1.53 $9,311 D/D (6,095) 279,998 11%     
   Colvin Richard A Chief Medical Officer   •       –      –    2024-03-01 4 S $1.53 $10,342 D/D (6,770) 118,368 13%     
   Obenshain Andrew President and CEO   •       •      –    2024-02-05 4 S $0.90 $1,696 D/D (1,879) 286,093 -51%     
   Vittiglio Joseph Chief Business & Legal Officer   •       –      –    2024-02-05 4 S $0.90 $4,708 D/D (5,217) 44,783 -51%     
   Klima Thomas J See Remarks   •       –      –    2024-02-05 4 S $0.90 $2,449 D/D (2,714) 129,413 -51%     
   Colvin Richard A Chief Medical Officer   •       –      –    2024-01-05 4 S $1.42 $845 D/D (597) 125,138 4%     
   Obenshain Andrew President and CEO   •       •      –    2024-01-05 4 S $1.43 $4,520 D/D (3,162) 287,972 4%     
   Krawtschuk Christopher Chief Financial Officer   •       –      –    2023-12-06 4 S $4.52 $20,437 D/D (4,526) 45,474 72%     
   Klima Thomas J See Remarks   •       –      –    2023-09-05 4 S $3.79 $3,493 D/D (922) 132,127 60%     
   Obenshain Andrew President and CEO   •       •      –    2023-08-10 4 S $3.54 $59,956 D/D (16,929) 291,941 10%     
   Klima Thomas J See Remarks   •       –      –    2023-06-02 4 S $3.50 $14,451 D/D (4,130) 133,049 21%     
   Paulson Richard A.   –       •      –    2023-04-03 4 A $0.00 $0 D/D 4,663 4,663     -
   Klima Thomas J See Remarks   •       –      –    2023-03-01 4 A $0.00 $0 D/D 55,000 137,179     -
   Colvin Richard A Chief Medical Officer   •       –      –    2023-03-01 4 A $0.00 $0 D/D 55,000 128,078     -
   Obenshain Andrew President and CEO   •       •      –    2023-03-01 4 A $0.00 $0 D/D 67,600 308,870     -
   Colvin Richard A Chief Medical Officer   •       –      –    2023-02-01 4 D $6.38 $7,356 D/D (1,153) 73,078     -
   Obenshain Andrew President and CEO   •       •      –    2023-02-01 4 D $6.38 $9,060 D/D (1,420) 241,270     -
   Klima Thomas J See Remarks   •       –      –    2023-02-01 4 D $6.38 $14,419 D/D (2,260) 82,179     -
   Vittiglio Joseph Chief Business & Legal Officer   •       –      –    2023-02-01 4 A $0.00 $0 D/D 50,000 50,000     -
   Colvin Richard A Chief Medical Officer   •       –      –    2023-01-11 4 S $7.80 $4,347 D/D (557) 74,231 53%     
   Leschly Nick   –       •      –    2023-01-11 4 S $7.80 $33,480 D/D (4,290) 280,149 53%     
   Obenshain Andrew President and CEO   •       •      –    2023-01-11 4 S $7.80 $24,802 D/D (3,178) 242,690 53%     
   Krawtschuk Christopher Chief Financial Officer   •       –      –    2022-12-01 4 A $0.00 $0 D/D 50,000 50,000     -
   Obenshain Andrew President and CEO   •       •      –    2022-11-04 4 S $6.41 $8,101 D/D (1,263) 245,868 27%     

  939 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 38
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed